The present invention can provide a cancer treatment drug containing, as an active ingredient, a substance selected from the group consisting of an indazole compound of the following formula (I), a pharmaceutically acceptable salt, a hydrate, a water adduct and a solvate:
NEW DISUBSTITUTED PHENYLPIPERIDINES AS MODULATORS OF DOPAMINE AND SEROTONIN NEUROTRANSMISSION
申请人:Sonesson Clas
公开号:US20070179185A1
公开(公告)日:2007-08-02
The present invention relates to compounds which have therapeutic effects against disorders in the central nervous system, and in particular new 4-(ortho,meta-disubstituted phenyl)-1-alkypiperidines.
wherein R1, R2, and R3 are as defined.
[EN] NEW DISUBSTITUTED PHENYLPIPERIDINES AS MODULATORS OF DOPAMINE AND SEROTONIN NEUROTRANSMISSION<br/>[FR] NOUVEAUX PHENYLPIPERIDINES DISUBSTITUE UTILISES COMME MODULATEURS DE LA NEUROTRANSMISSION DE LA DOPAMINE ET DE LA SEROTONINE
申请人:CARLSSON A RESEARCH AB
公开号:WO2005121088A1
公开(公告)日:2005-12-22
The present invention relates to compounds which have therapeutic effects against disorders in the central nervous system, and in particular new 4-(ortho,meta disubstituted phenyl)-1-alkypiperidines. (I) wherein R1, R2, and R3 are as defined.